Global Trade & Tariffs
U.S. Pharma Tariffs Force a Reckoning on China-India API Dominance
Forget the hype about quick fixes. These tariffs expose pharma's Achilles' heel: 70-80% of APIs from China and India. Chains built for efficiency now face policy bulldozers.